TG Therapeutics, Inc. (MHA) Approved for Listing on the NASDAQ Capital Market
5/28/2013 8:59:53 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NEW YORK, May 28, 2013 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (TGTX), an innovative clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs, today announced that its common stock has been approved for listing on the NASDAQ Capital Market (NASDAQ) and is expected to commence trading on NASDAQ under the ticker symbol "TGTX" on May 30, 2013. The Company's common stock will continue to trade on the Over-the-Counter Bulletin Board until the market close on May 29, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by